Patent · US Active

Sting modulator compounds, and methods of making and using

US12054512B2 · kind B2 · utility

0Cited by

18References

23Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Stepan Vyskocil · Arlington, US
Jeffrey P. Ciavarri · Reading, US
Courtney A. Cullis · Bedford, US
Dylan Bradley ENGLAND · Cambridge, US
Alexandra E. Gould · Cambridge, US
Paul Greenspan · New Providence, US
Yongbo Hu · Winchester, US
Steven P. Langston · North Andover, US
Gang Li · Beijing, CN
Hirotake Mizutani · Cambridge, US
Masanori Okaniwa · Osaka, JP

Key dates

Filing date	Nov 2, 2022
Grant date	Aug 6, 2024
Priority date	—
Expiry date	Nov 2, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H21/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present disclosure provides STING modulators/agonists, and methods of synthesis and methods for using for the prophylaxis or treatment of cancer and other STING-related diseases.The present disclosure relates to a compound represented by the Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.